67750 Federal Register / Vol. 65, No. 219 / Monday, November 13, 2000 / Notices

duplicate current and widely available

research syntheses, unless new evidence

is available that suggests the need for

revisions or updates.

For each topic, nominators should

provide a rationale and supporting

evidence on the importance and

relevance of the topic. Nominators must

also state their plans for use of the

evidence report and indicate how the

report could be used by public and

private decision makers. Nomination

information should include:

• Defined organizational/financial

arrangement or structure impacting

quality, outcomes, cost, access or use.

• Three to five specific questions to

be answered.

• If appropriate, description of how

the organizational/financial

arrangement or structure is particularly

relevant to delivery of care for specific

vulnerable populations (e.g., children,

persons with chronic disease) or certain

communities (e.g., rural markets).

• Costs potentially affected by the

organizational/financial arrangement, to

the extent they can be quantified.

• Impact potential of the evidence

report to decrease health care costs or to

improve health status or outcomes.

• Availability of scientific and/or

administrative data and bibliographies

of studies on the topic.

• References to significant variation

in delivery and financing patterns and/

or results, and related controversies.

• Nominator’s plan for use of an

evidence report on this topic.

• Nominator’s plan for measuring the

impact of the report on practice.

Selection Criteria for Organization and

Financing Topics

Factors that will be considered in the

selection of topics related to the

organization and financing of care

include the following: (1) Uncertainty

about the impact of the subject

organizational or financing strategy; (2)

potential for the subject organizational

or financing strategy or the proposed

research synthesis to significantly

impact aggregate health care costs; (3)

policy-relevant to Medicare, Medicaid,

and/or other Federal and State health

programs; (4) relevant to vulnerable

populations, including racial and ethnic

minorities, and particular communities,

such as rural markets; (5) available

scientific data to support systematic

review and analysis of the topic; (6)

demonstrated commitment by the

nominating organization to incorporate

the report into its managerial or policy

decision-making; and (7) plans by the

nominating organization to measure the

impact of the report on practice.

Dated: November 2, 2000.

John M. Eisenberg,

Director.

[FR Doc. 00–28896 Filed 11–9–00; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Board of Scientific Counselors,

National Center for Infectious

Diseases: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Board of Scientific Counselors,

National Center for Infectious Diseases

(NCID).

Times and Dates: 9 a.m.–5:45 p.m.,

December 7, 2000, 8:30 a.m.–2:30 p.m.,

December 8, 2000.

Place: CDC, Roybal Building 17 Conference

Room, 1600 Clifton Road, Atlanta, Georgia

30333.

Status: Open to the public, limited only by

the space available.

Purpose: The Board of Scientific

Counselors, NCID, provides advice and

guidance to the Director, CDC, and Director,

NCID, in the following areas: program goals

and objectives; strategies; program

organization and resources for infectious

disease prevention and control; and program

priorities.

Matters to be Discussed: Agenda items will

include:

1. Opening Session: NCID Update

2. CDC Facilities Master Plan, Fort Collins,

Colorado

3. Program Update: Patient Safety and

Quality Care

4. Issue Updates

a. NCID Research Agenda

b. Planning and Communication Strategies

c. Global Infectious Disease Strategic Plan

5. Tour of Roybal Building 17

6. Breakout groups on Issue Updates (Item 4,

a–c above)

7. Program Update: West Nile Virus

8. Breakout Group Report/Discussion: NCID

Research Agenda

9. Breakout Group Report/Discussion:

Planning and Communication Strategies

10. Breakout Group Report/Discussion:

Global Infectious Disease Strategic Plan

11. Late Breakers: Scientific Outbreak

Reports

12. Discussions and Recommendations

Other agenda items include

announcements/introductions; follow-up on

actions recommended by the Board May

2000; consideration of future directions,

goals, and recommendations.

Agenda items are subject to change as

priorities dictate.

Written comments are welcome and should

be received by the contact person listed

below prior to the opening of the meeting.

CONTACT PERSON FOR MORE INFORMATION:

Diane S. Holley, Office of the Director,

NCID, CDC, Mailstop C–20, 1600 Clifton

Road, NE, Atlanta, Georgia 30333, email

dsy1@cdc.gov; telephone 404/639–0078.

The Director, Management Analysis

and Services office has been delegated

the authority to sign Federal Register

notices pertaining to announcements of

meetings and other committee

management activities, for both the

Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: November 6, 2000.

Carolyn J. Russell,

Management Analysis and Services Office,

Centers for Disease Control and Prevention.

[FR Doc. 00–28898 Filed 11–9–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Board of Scientific Counselors,

National Institute for Occupational

Safety and Health: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub.L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting:

Name: Board of Scientific Counselors,

National Institute for Occupational Safety

and Health (BSC, NIOSH).

Time and Date: 9 a.m.–3:30 p.m.,

November 28, 2000.

Place: The Washington Court, 525 New

Jersey Avenue, NW., Washington, DC 20001–

1527.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Purpose: The BSC, NIOSH is charged with

providing advice to the Director, NIOSH on

NIOSH research programs. Specifically, the

Board shall provide guidance on the

Institute’s research activities related to

developing and evaluating hypotheses,

systematically documenting findings, and

disseminating results.

Matters To Be Discussed: Agenda items

include a report from the Director of NIOSH;